...
首页> 外文期刊>Health affairs >Nonopioid Overdose Death Rates Rose Almost As Fast As Those Involving Opioids, 1999-2016
【24h】

Nonopioid Overdose Death Rates Rose Almost As Fast As Those Involving Opioids, 1999-2016

机译:非缺点过量的死亡率几乎与涉及阿片类药物的那些速度迅速,1999-2016

获取原文
获取原文并翻译 | 示例
           

摘要

The number of Americans dying from drug overdoses has risen rapidly, but the contribution of nonopioid drugs to this growth is not well understood. Using vital statistics data from the universe of deaths among US residents in the period 1999-2016, I calculated levels of and increases in overall nonopioid fatal overdose rates and those for subgroups stratified by manner of death, sex, race/ethnicity, and age. Mortality rates were also calculated separately for sedatives, stimulants, antidepressants, and cocaine. Recently developed methods were used to correct for the incomplete reporting of drug involvement on death certificates. From 1999 to 2016 the number of nonopioid drug deaths rose 274 percent, and deaths per 100,000 population rose by 223 percent. Over the same period, opioid-involved fatality counts and rates grew by 371 percent and 307 percent, respectively. Fatal overdose rates involving stimulants increased more than tenfold, with slower growth but higher rates for deaths involving sedatives and cocaine. Midlife non-Hispanic whites generally experienced the highest levels and rise in nonopioid death rates, but cocaine fatality rates were particularly common among nonwhite or Hispanic males ages 40-59. Policies designed to curb the opioid epidemic are probably helpful in reducing nonopioid deaths, but targeted interventions may also be needed.
机译:从药物过度消亡的美国人数量迅速上升,但非磷药物对这种增长的贡献尚不清楚。在1999 - 2016年期间,使用来自美国居民死亡宇宙的重要统计数据,我计算了整体非缺乏症致命过量率的水平和增加,通过死亡,性别,种族/种族和年龄分层分层的亚组。对于镇静剂,兴奋剂,抗抑郁药和可卡因也单独计算死亡率。最近开发的方法用于纠正药物参与死亡证明的不完整报告。从1999年到2016年,非磷药物死亡人数上升了274%,每10万人的死亡人口增长了223%。在同一时期,阿片类药物涉及的死亡计数和率分别增长了371%和307%。涉及兴奋剂的致命过量率增加超过十倍,增长较慢,但涉及镇静剂和可卡因的死亡率较高。中期非西班牙裔白人通常经历了最高水平,非磷死亡率升高,但可卡因死亡率在40-59岁的非白人或西班牙裔男性中特别常见。设计用于抑制阿片类药物流行病的政策可能有助于减少非磷毒性死亡,但也可能需要有针对性的干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号